Related references
Note: Only part of the references are listed.Kinetics of protein-ligand unbinding: Predicting pathways, rates, and rate-limiting steps
Pratyush Tiwary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Revealing the favorable dissociation pathway of type II kinase inhibitors via enhanced sampling simulations and two-end-state calculations
Huiyong Sun et al.
SCIENTIFIC REPORTS (2015)
Targeted Therapies for Cutaneous Melanoma
Damien Kee et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2014)
Unbinding Pathways of VEGFR2 Inhibitors Revealed by Steered Molecular Dynamics
Anna Maria Capelli et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Exploration of the antagonist CP-376395 escape pathway for the corticotropin-releasing factor receptor 1 by random acceleration molecular dynamics simulations
Qifeng Bai et al.
MOLECULAR BIOSYSTEMS (2014)
Drug-Target Residence Time-A Case for G Protein-Coupled Receptors
Dong Guo et al.
MEDICINAL RESEARCH REVIEWS (2014)
Computational Study on the Inhibitor Binding Mode and Allosteric Regulation Mechanism in Hepatitis C Virus NS3/4A Protein
Weiwei Xue et al.
PLOS ONE (2014)
Molecular Modeling Study on the Allosteric Inhibition Mechanism of HIV-1 Integrase by LEDGF/p75 Binding Site Inhibitors
Weiwei Xue et al.
PLOS ONE (2014)
P-loop Conformation Governed Crizotinib Resistance in G2032R-Mutated ROS1 Tyrosine Kinase: Clues from Free Energy Landscape
Huiyong Sun et al.
PLOS COMPUTATIONAL BIOLOGY (2014)
Antitumor Activity of the Selective Pan-RAF Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma
Akito Nakamura et al.
CANCER RESEARCH (2013)
Enhanced Inhibition of ERK Signaling by a Novel Allosteric MEK Inhibitor, CH5126766, That Suppresses Feedback Reactivation of RAF Activity
Nobuya Ishii et al.
CANCER RESEARCH (2013)
Discovery of a Selective Kinase Inhibitor (TAK-632) Targeting Pan-RAF Inhibition: Design, Synthesis, and Biological Evaluation of C-7-Substituted 1,3-Benzothiazole Derivatives
Masanori Okaniwa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Free energy landscape for the binding process of Huperzine A to acetylcholinesterase
Fang Bai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations
Tingjun Hou et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Exploring coumarin egress channels in human cytochrome P450 2A6 by random acceleration and steered molecular dynamics simulations
Weihua Li et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2011)
Drug-target residence time: critical information for lead optimization
Hao Lu et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
MM-GBSA binding free energy decomposition and T cell receptor engineering
V. Zoete et al.
JOURNAL OF MOLECULAR RECOGNITION (2010)
Ligand unbinding pathways from the vitamin D receptor studied by molecular dynamics simulations
Mikael Perakyla
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2009)
Standard Free Energy of Binding from a One-Dimensional Potential of Mean Force
Slimane Doudou et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2009)
Ligand Entry and Exit Pathways in the β2-Adrenergic Receptor
Ting Wang et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Pathways and Mechanisms for Product Release in the Engineered Haloalkane Dehalogenases Explored Using Classical and Random Acceleration Molecular Dynamics Simulations
Martin Klvana et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Comparison of computational approaches for predicting the effects of missense mutations on p53 function
Lillian T. Chong et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2009)
Residence time of receptor-ligand complexes and its effect on biological function
Peter J. Tummino et al.
BIOCHEMISTRY (2008)
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7
Narendra Wajapeyee et al.
CELL (2008)
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
James Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
James A. McCubrey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Raf kinases: Function, regulation and role in human cancer
Deborah T. Leicht et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Chromophore channeling in the G-protein coupled receptor rhodopsin
Ting Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Protein-protein recognition and interaction hot spots in an antigen-antibody complex: Free energy decomposition identifies efficient amino acids
Virginie Lafont et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2007)
Comparison between computational alanine scanning and per-residue binding free energy decomposition for protein-protein association using MM-GBSA: Application to the TCR-p-MHC complex
Vincent Zoete et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2007)
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma
Ghassan K. Abou-Alfa et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Opinion - Drug-target residence time and its implications for lead optimization
Robert A. Copeland et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Scalable molecular dynamics with NAMD
JC Phillips et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
The Amber biomolecular simulation programs
DA Case et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
BRAFE600-associated senescence-like cell cycle arrest of human naevi
C Michaloglou et al.
NATURE (2005)
Do mammalian cytochrome P450s show multiple ligand access pathways and ligand channelling?
K Schleinkofer et al.
EMBO REPORTS (2005)
Randomized phase III trial of the Raf kinase and VEGFR inhibitor sorafenib (BAY 43-9006) in patients with advanced renal cell carcinoma (RCC).
B Escudier et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Calculating potentials of mean force from steered molecular dynamics simulations
S Park et al.
JOURNAL OF CHEMICAL PHYSICS (2004)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Accelerated molecular dynamics: A promising and efficient simulation method for biomolecules
D Hamelberg et al.
JOURNAL OF CHEMICAL PHYSICS (2004)
Exploring protein native states and large-scale conformational changes with a modified generalized born model
A Onufriev et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
Free energy calculation from steered molecular dynamics simulations using Jarzynski's equality
S Park et al.
JOURNAL OF CHEMICAL PHYSICS (2003)
Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RaIGDS complexes
H Gohlke et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
High frequency of BRAF mutations in nevi
PM Pollock et al.
NATURE GENETICS (2003)
Steered molecular dynamics and mechanical functions of proteins
B Isralewitz et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2001)
How do substrates enter and products exit the buried active site of cytochrome P450cam?: 1.: Random expulsion molecular dynamics investigation of ligand access channels and mechanisms
SK Lüdemann et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Share Paper
